Physician

Mark R Mcandrew, M.D.

According to 2025 Medicare claims, Mark Mcandrew, M.D. (NPI: 1740281674) practices general surgery in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Dearborn, IN. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP, INC (NPI: 1750343216; TIN: 611300608) and primary practice location at 47025-2751. Mcandrew is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Mcandrew's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 263 traditional Medicare patients, billed 733 HCPCS/CPT codes, and received $65,417 in Medicare payments. The top billing code was 45380 (Biopsy of large bowel using a flexible endoscope). Part D data shows 217 prescription claims across 112 beneficiaries totaling $4,204 in drug costs, led by Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates). 2021 DME data shows 15 claims. Open Payments data shows 19 records totaling $849. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $146,831 to $65,417. In contrast, Part D prescription costs have moved sharply higher in recent years, from $4,662 to $4,204. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $7,572 and ending at $5,529.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	504	1,744	$146,831
2016	524	1,826	$147,916
2017	500	1,575	$131,868
2018	523	1,608	$131,387
2019	491	1,279	$110,313
2020	355	932	$86,552
2021	430	1,262	$113,492
2022	467	1,463	$124,020
2023	381	911	$78,853
2024	263	733	$65,417

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	118	269	$4,662
2016	115	258	$3,963
2017	126	275	$4,436
2018	158	303	$6,379
2019	131	248	$8,571
2020	134	249	$8,718
2021	201	316	$18,949
2022	224	371	$24,073
2023	180	300	$15,585
2024	112	217	$4,204

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$1,201
2019	N/R	45	$4,437
2020	N/R	27	$3,003
2021	N/R	15	$4,356
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45380	Biopsy of large bowel using a flexible endoscope	39	40	$110
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	44	49	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	69	78	$83
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	46	143	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	139	$49

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	18	21	$1,154
Pantoprazole Sodium	Pantoprazole Sodium	70	4,345	$419
Sucralfate	Sucralfate	29	1,080	$389
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	11	11	$115
Ibuprofen	Ibuprofen	23	234	$58

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$849	W. L. Gore & Associates, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark R. Mcandrew, M.D.?

Tedicare shows public-source Medicare data for Mark R. Mcandrew, M.D. (NPI 1740281674), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark R. Mcandrew, M.D. have ACO affiliation data?

Mark R. Mcandrew, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Mark R. Mcandrew, M.D.?

Mark R. Mcandrew, M.D. is linked to SUMMIT MEDICAL GROUP, INC (billing NPI 1750343216) in the available physician profile data.

Does Mark R. Mcandrew, M.D. have Open Payments data?

Mark R. Mcandrew, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.